| Cedarburg Health Services | |
| N27 W5707 Lincoln Blvd, Cedarburg, Wisconsin 53012 | |
| (262) 376-7676 | |
| Name | Cedarburg Health Services |
|---|---|
| Location | N27 W5707 Lincoln Blvd, Cedarburg, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 78 |
| Occupancy Rate | 49.23% |
| Medicare ID (CCN) | 525578 |
| Legal Business Name | Nsh Cedarburg Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1033282116 |
| Organization Name | EXTENDICARE HOMES, INC. |
| Doing Business As | CEDAR SPRINGS HEALTH & REHABILITATION CENTER |
| Address | N27w5707 Lincoln Blvd, Cedarburg, WI 53012 |
| Phone Number | 262-376-7676 |
News Archive
The Emily Program - a nationally recognized eating disorder treatment center- today announced plans to open a new office in Olympia, WA, its 3rd location in the Seattle area, 4th location in the Pacific Northwest.
Antibiotic resistance is one of the most challenging problems in modern medicine. A new study by Erida Gjini and Patricia H. Brito from the Instituto Gulbenkian de Ciência, provides a new mathematical model to evaluate the best treatment protocol to clear an infection, by taking into account the role of the host immune system.
Two HIV policy experts from the O'Neill Institute for National and Global Health Law at Georgetown Law working in partnership with NMAC have released the first of two reports to help prevent HIV in communities of color.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its 2009 net earnings were approximately $16.4 million, or $0.33 per diluted share, compared with approximately $12.8 million, or $0.27 per diluted share, in 2008. Net revenues were approximately $57.8 million in 2009 compared with $73.8 million in 2008.
› Verified 7 days ago
| NPI Number | 1215329537 |
| Organization Name | FMG LINCOLN BOULEVARD WISCONSIN LLC |
| Doing Business As | CEDAR SPRINGS HEALTH AND REHABILITATION CENTER |
| Address | N27w5707 Lincoln Blvd, Cedarburg, WI 53012 |
| Phone Number | 262-376-7676 |
News Archive
The Emily Program - a nationally recognized eating disorder treatment center- today announced plans to open a new office in Olympia, WA, its 3rd location in the Seattle area, 4th location in the Pacific Northwest.
Antibiotic resistance is one of the most challenging problems in modern medicine. A new study by Erida Gjini and Patricia H. Brito from the Instituto Gulbenkian de Ciência, provides a new mathematical model to evaluate the best treatment protocol to clear an infection, by taking into account the role of the host immune system.
Two HIV policy experts from the O'Neill Institute for National and Global Health Law at Georgetown Law working in partnership with NMAC have released the first of two reports to help prevent HIV in communities of color.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its 2009 net earnings were approximately $16.4 million, or $0.33 per diluted share, compared with approximately $12.8 million, or $0.27 per diluted share, in 2008. Net revenues were approximately $57.8 million in 2009 compared with $73.8 million in 2008.
› Verified 7 days ago
| NPI Number | 1891213625 |
| Organization Name | NSH CEDARBURG LLC |
| Address | N27w5707 Lincoln Blvd, Cedarburg, WI 53012 |
| Phone Number | 262-376-7676 |
News Archive
The Emily Program - a nationally recognized eating disorder treatment center- today announced plans to open a new office in Olympia, WA, its 3rd location in the Seattle area, 4th location in the Pacific Northwest.
Antibiotic resistance is one of the most challenging problems in modern medicine. A new study by Erida Gjini and Patricia H. Brito from the Instituto Gulbenkian de Ciência, provides a new mathematical model to evaluate the best treatment protocol to clear an infection, by taking into account the role of the host immune system.
Two HIV policy experts from the O'Neill Institute for National and Global Health Law at Georgetown Law working in partnership with NMAC have released the first of two reports to help prevent HIV in communities of color.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its 2009 net earnings were approximately $16.4 million, or $0.33 per diluted share, compared with approximately $12.8 million, or $0.27 per diluted share, in 2008. Net revenues were approximately $57.8 million in 2009 compared with $73.8 million in 2008.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The Emily Program - a nationally recognized eating disorder treatment center- today announced plans to open a new office in Olympia, WA, its 3rd location in the Seattle area, 4th location in the Pacific Northwest.
Antibiotic resistance is one of the most challenging problems in modern medicine. A new study by Erida Gjini and Patricia H. Brito from the Instituto Gulbenkian de Ciência, provides a new mathematical model to evaluate the best treatment protocol to clear an infection, by taking into account the role of the host immune system.
Two HIV policy experts from the O'Neill Institute for National and Global Health Law at Georgetown Law working in partnership with NMAC have released the first of two reports to help prevent HIV in communities of color.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its 2009 net earnings were approximately $16.4 million, or $0.33 per diluted share, compared with approximately $12.8 million, or $0.27 per diluted share, in 2008. Net revenues were approximately $57.8 million in 2009 compared with $73.8 million in 2008.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $19237 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.94 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.4 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 53.73 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.17 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.76 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 3.42 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.68 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 88.36 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 75.35 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.26 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 29.17 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.95 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.48 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.02 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 78.95 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 78.22 | 82.93 |
News Archive
The Emily Program - a nationally recognized eating disorder treatment center- today announced plans to open a new office in Olympia, WA, its 3rd location in the Seattle area, 4th location in the Pacific Northwest.
Antibiotic resistance is one of the most challenging problems in modern medicine. A new study by Erida Gjini and Patricia H. Brito from the Instituto Gulbenkian de Ciência, provides a new mathematical model to evaluate the best treatment protocol to clear an infection, by taking into account the role of the host immune system.
Two HIV policy experts from the O'Neill Institute for National and Global Health Law at Georgetown Law working in partnership with NMAC have released the first of two reports to help prevent HIV in communities of color.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its 2009 net earnings were approximately $16.4 million, or $0.33 per diluted share, compared with approximately $12.8 million, or $0.27 per diluted share, in 2008. Net revenues were approximately $57.8 million in 2009 compared with $73.8 million in 2008.
› Verified 7 days ago
Cedarburg Health Services Location: N27 W5707 Lincoln Blvd, Cedarburg, Wisconsin 53012 Phone: (262) 376-7676 |